Since Americans started importing medications for personal use in larger numbers at the beginning of the last decade, the Pharmaceutical Researchers and Manufacturers of America (PhRMA), Big Pharma, has engaged in media and government relations scare tactics to try and stop them. Apparently, when it comes to foreign versions of the new FDA-Approved Emflaza, which treats Duchenne Muscular Dystrophy, one board member of PhRMA supports importation!
Last week, I wrote about the decision of drug company Marathon Pharmaceuticals to postpone selling Emflaza over pricing concerns and how the issue shines a bright light on the benefits of personal drug importation. To summarize: some folks are outraged because Emflaza (deflazacort) was launched at a price of $89,000 for a one year supply. This seems insane when foreign versions of deflazacort, which cost 1% that amount (less than $1000), are already imported for personal use.
PhRMA is trying to distance itself from Marathon, just like it did with Martin Shkreli, former CEO of Turning Pharmaceuticals, when the price of Daraprim jumped from $13.50 to $750 a pill overnight. The CEO of Marathon, Jeff Aronin, however, sits on PhRMA’s Board of Directors! Last week, John Carroll of Endpoints News predicted last week that Aronin might be dropped. As of today, he’s still there.
Mr. Aronin wrote a letter to the Duchenne community that fully acknowledged American kids were already being treated with an unapproved foreign version of deflazacort. In his words: “As we all know, deflazacort was being used without FDA approval — and without ever having been approved anywhere in the world for Duchenne — by a very small group of patients (roughly 7 to 9 percent) in the Duchenne community who imported it from overseas.”
But does he support it? I mean, after all, the “score” for Marathon is that once it’s available for sale in the U.S., it will be purchased here. At least for the time being, this PhRMA board member does support it and seems to have no concern whatsoever whether the foreign version is safe and effective, not should he, since, like other medications, it was approved for safety and efficacy elsewhere. In noting that Marathon will “pause our commercialization” of Emflaza,” maintain its Expanded Access Patient Assistance Program, Aronin also state: “Patients currently receiving deflazacort from other sources may continue to have that option.” Damn right.
Is it hypocritical of PhRMA to diss Marathon? After all, brand drug companies jacked prices 130 times the inflation rate in 2015. Forty-five million Americans didn’t fill a prescription in 2016 due to cost. PhRMA will continue its practice of legal bribery and unleash a new, shiny PR campaign about life sciences and innovation — to prevent legislative and regulatory reforms that would lower drug prices. It’s going to take an unpredictable, unexpected populist wave of American anger at drug companies to bring their house down. In the meantime, maybe the people will take a hint from one PhRMA board member and import unapproved and lower cost medications.
Tagged with: aronin, Big Pharma, deflazacort, emflaza, marathon, phrma
Can Big Pharma Help Me Afford My Meds?
People who are not new to this blog know that we are often critical of the pharmaceutical industry because of their actions to stop Americans from buying lower cost medications from international online pharmacies. So, this may come as a surprise…
Today, we announced that we have added a new section on PharmacyChecker.com for consumers to search, find and apply to patient assistance programs, those sponsored by pharmaceutical companies. You can type in the name of your medication and review a very comprehensive collection of these programs, including low-cost, no-cost, and copay programs. The eligibility hurdles are often prohibitive: so please understand that for many programs, if you’re currently earning above the median income in the U.S. it’s likely that you are too rich. (more…)
Don’t blame poor little Big Pharma
Big Pharma is in the mood to share! A new report commissioned by the Pharmaceutical Researchers and Manufacturers of America (PhRMA), the trade association representing the world’s largest global pharmaceutical companies, seems to assert that the blame for high drug prices should be shared with pharmacy benefit managers, retail pharmacies, wholesalers, and, I think, even hospitals – and more. It appears that PhRMA’s main target is the pharmaceutical benefit managers.
Noting that President Donald Trump recently said drug companies are “getting away with murder” – I view this report as pharma’s attempt to communicate, “hey, prez, we’re not alone here in being greedy.” The report has merit, which I’ll explain below when looking at the dollar numbers. But as far as the American consumer is concerned: murder is murder. Hey, I’m just using the president’s words. Due to the killing made by pharma and friends (because they’re all friends), 10s of millions of Americans are leaving their scripts unfilled because the prices, one way or the other, are out of reach.
The report is called “The Pharmaceutical Supply Chain: Gross Drug Expenditures Realized by Stakeholders.” You can find a summary of it here but this is my take on it. (more…)
Tagged with: phrma, supply chain
It’s time to get real
In 2005, as reported here, an executive from the Pharmaceutical Researchers and Manufacturers of America (PhRMA or Big Pharma), agreed to commission, to the tune of $300,000, the writing of a fictional novel in which Muslim terrorists poison prescription drugs in Canada to kill Americans who – seeking affordable medication – buy drugs from Canada. The deal with the publisher didn’t work out. As the authors tell it, PhRMA offered money to shut them up but they said no. They instead wrote a book about a pharmaceutical company who poisoned Canadian drugs and made it look like Muslim terrorists did it. Nope, I couldn’t make this up. That book – The Karasik Conspiracy – is available on Amazon.
Fake news is in the news a lot lately! Like fake news, efforts to dissuade Americans from obtaining safe lower cost medication through personal drug importation can have dangerous consequences: people scared away from safe medication they can afford. There are – in fact – very safe international online pharmacies and dangerous rogue pharmacy sites. Stick to the former avoid the latter. There are tens of millions of Americans not taking medications because of cost — so it’s time to get real. (more…)
Tagged with: AEI, fake news, medscape, Roger Bate, webmd, who
For the record, while I supported Obama for president, I was highly critical of the Obama administration for its obscenely cozy relationship with the pharmaceutical industry, one that has led to unprecedented increases in drug prices during his tenure. During his first presidential campaign, President Obama had vowed to stand up to drug companies, and he supported allowing Americans to import medication to find savings in other countries. He ended up making a deal with Big Pharma to help him pass Obamacare, dumping his support for Medicare drug prices negotiations and importation.
Candidate Donald Trump voiced his support for federal drug price negotiations to bring down drug prices under Medicare and allowing consumers access to lower drug prices from overseas. Those are two policies that the pharmaceutical industry has spent hundreds of millions of dollars defeating over the past decade through large contributions to Democrats and Republican alike in Congress. Of course, Americans can order medications online from foreign countries and import them for personal use, but under the Obama administration it has become more difficult and remains technically illegal.
Mr. Trump states on his website: “Congress will need the courage to step away from the special interests and do what is right for America.” During the Republican Primary President-Elect Trump vowed to stand up to the drug companies, mocking the career politicians who take their money and do their bidding in Congress.
From the Right, Americans who hate the heavy hand of big government will laud a President Trump that tells the FDA not to interfere with their freedom to purchase a lower cost medication from Canada or another country. From the Left and in states that border Canada, such as Michigan, Americans would love to see a president who will stand up to the outrageous U.S. pricing policies of multinational pharmaceutical companies by taking actions to expand access lower cost imported medications.
With high drug prices viewed as the #1 healthcare cost concern in the county, ALL AMERICANS WANT TO SEE TRUMP STAND UP TO BIG PHARMA.
Now let’s see if he does.
Tagged with: trump
A paid “news release” this week by the Alliance for Safe Online Pharmacies (ASOP) and LegitScript and widely disseminated by PR Newswire’s MultiView – deceitfully and incorrectly associated PharmacyChecker.com with a federal indictment involving the wholesale operations of a Canadian company. [UPDATE: After PR Newswire was informed by our attorneys of the libelous nature of the ASOP/LegitScript news release, PR Newswire removed it. The release had appeared at http://www.multivu.com/players/English/7602051-asop-doj-indictment-prescription-drugs/ ]
A former consultant to PharmacyChecker.com was, unfortunately, swept up in this indictment for an action having nothing to do with his work with PharmacyChecker.com (see our posting about the indictment) [UPDATE: The charges against this individual were dismissed on October 20].
But even though PharmacyChecker, nor any of its executives or employees, are the subject of the recent indictment or even mentioned in it, ASOP and LegitScript, who we see as sharks for Big Pharma and Big Pharmacy, could not resist throwing a public relations party, which we believe is aimed at manipulating the media and reporters, government, and worse – consumers! It appears that they spent a lot of money on a PR firm, ECI Communications, to put together and disseminate lies about PharmacyChecker.com and misleading information about international online pharmacies.
Want proof? After reading ASOP and LegitScript’s deceitfully misleading news release, a writer at the publication Medicine Marketing & Media was apparently duped into writing on Wednesday that PharmacyChecker was being indicted! After we contacted that publication about the inaccuracy, we were swiftly given an apology, the article was corrected, and the following statement posted: “CORRECTION: An earlier version of this story incorrectly listed PharmacyChecker.com as a defendant. PharmacyChecker.com is not a defendant in the case.
A renowned expert in First Amendment Law considers the news release “libelous” and ASOP, LegitScript, and ECI have been asked to take it down. PR Newswire has also been asked to remove it, as it appears to violate PR Newswire’s own guidelines regarding libelous content and this certainly doesn’t help their existing reputation for distributing “low quality content.” However, perhaps due to the enormous funding behind these groups, they have yet to make any attempt to correct the situation. We’ll see how much they care about the truth by their actions.
It’s important to keep in mind who these groups are. ASOP’s members and funders include large pharmaceutical companies and the National Association of Chain Drugstores. To protect their bottom lines, these companies and ASOP lobby congress and federal agencies, such as the FDA, to try to curtail your access to much more affordable and safe medication from outside the U.S. In fact, ASOP is actually located in the offices of the government relations and communications consulting firm FraegreBD, where ASOPs executive director, also happens to be a Vice President. And ECI Communications is a PR firm which does extensive business for U.S. pharmaceutical companies. Of course LegitScript.com happens to be a founding member of ASOP. Can we trust LegitScript.com or ASOP? Well, you already know who ASOP works for, right? On the other hand, much of LegitScript.com’s income is from a contract with the FDA for $5.2 million. That’s not bad in and of itself but, if that money is being used to spread misinformation to U.S. consumers and lobby congress and maybe even the FDA itself, then that stinks.
The truth is that American consumers are buying medication from outside the U.S., five million of them each year, because many of them can’t afford prices in the U.S. Since 2003, PharmacyChecker.com has been working hard to publish information that helps Americans find safe and affordable medication from these pharmacies. Yet it seems the only safe online pharmacy to ASOP is one that is approved by LegitScript.com, which in turn believes that every pharmacy outside the U.S. that sells into the U.S. including licensed pharmacies in Canada, are not “legitimate” or are “rogue.”
ASOP’s and LegitScript’s vision of “legitimacy” is a nightmare for Americans! Thirty-five million Americans don’t fill a script each year because of cost. A safe online pharmacy is not safe for a consumer who can’t afford the medications it sells. ASOP, LegitScript, the NABP, FDA, etc., can’t wish away the fact that safe international online pharmacies are a lifeline for many American consumers. Scaring these Americans away from safe pharmacy options with misleading and false information means that more Americans will go without their prescribed medications. There is nothing “safe” or “legit” about that.
Tagged with: Alliance for Safe Online Pharmacies, ASOP, Big Pharma, consumers, indictment